Document is current
Any future updates will be listed below
-
Authors
Ekberg, Sara https://orcid.org/0000-0002-7063-467X
Crowther, Michael
Harrysson, Sara
Jerkeman, Mats https://orcid.org/0000-0003-4509-6707
E. Smedby, Karin
Eloranta, Sandra
-
Funding
Funding for this research was provided by:
Cancerfonden (200705)
- License Information
-
More Information
Article History
Received: 17 January 2022
Revised: 14 July 2022
Accepted: 15 July 2022
First Online: 23 August 2022
Competing interests
: Sara Ekberg, SH, Sandra Eloranta and KES are part of a research collaboration between Karolinska Institutet and Janssen Pharmaceutica NV for which Karolinska Institutet has received grant support. KES has received Grant support from Janssen Pharmaceuticals and Takeda. MJ has received research support from Janssen Pharmaceuticals, Roche, Gilead, AstraZeneca and Abbvie and honoraria from Janssen Pharmaceuticals, Incyte, Gilead, AstraZeneca, Abbvie and Orion. MC has received consultancy fees from StataCorp LLC.
: The study was approved by the Regional Ethics Committee in Stockholm. All participants eligible for the medical record review had completed a written informed consent form.
: Not applicable.
